Safeguard Scientifics (NYSE:SFE) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Safeguard Scientifics (NYSE:SFE) in a research report sent to investors on Wednesday morning. The brokerage issued a hold rating on the asset manager’s stock.

Safeguard Scientifics Price Performance

SFE stock opened at $1.18 on Wednesday. The stock has a market cap of $19.49 million, a price-to-earnings ratio of -1.33 and a beta of 0.92. The company has a 50 day simple moving average of $1.34 and a 200 day simple moving average of $1.69. Safeguard Scientifics has a 1 year low of $1.02 and a 1 year high of $4.53.

Safeguard Scientifics (NYSE:SFE) last announced its quarterly earnings results on Thursday, August 10th. The asset manager reported ($0.18) earnings per share (EPS) for the quarter.

Insider Activity

In other news, major shareholder Thomas A. Satterfield, Jr. acquired 50,000 shares of the stock in a transaction dated Friday, August 18th. The stock was bought at an average price of $1.17 per share, with a total value of $58,500.00. Following the completion of the purchase, the insider now directly owns 525,000 shares of the company’s stock, valued at approximately $614,250. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 7.10% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Clayton Partners LLC raised its position in shares of Safeguard Scientifics by 15.7% during the first quarter. Clayton Partners LLC now owns 143,349 shares of the asset manager’s stock worth $247,000 after acquiring an additional 19,429 shares during the last quarter. Bank of America Corp DE raised its holdings in Safeguard Scientifics by 32,504.1% during the 1st quarter. Bank of America Corp DE now owns 128,786 shares of the asset manager’s stock worth $222,000 after purchasing an additional 128,391 shares during the last quarter. Yakira Capital Management Inc. lifted its position in shares of Safeguard Scientifics by 1.0% in the 1st quarter. Yakira Capital Management Inc. now owns 1,164,945 shares of the asset manager’s stock worth $2,004,000 after purchasing an additional 11,200 shares during the period. Almitas Capital LLC boosted its stake in shares of Safeguard Scientifics by 11.7% in the 4th quarter. Almitas Capital LLC now owns 796,632 shares of the asset manager’s stock valued at $2,470,000 after purchasing an additional 83,187 shares during the last quarter. Finally, Legal & General Group Plc increased its position in shares of Safeguard Scientifics by 5.3% during the second quarter. Legal & General Group Plc now owns 95,711 shares of the asset manager’s stock worth $357,000 after buying an additional 4,815 shares during the period. 44.14% of the stock is owned by institutional investors and hedge funds.

Safeguard Scientifics Company Profile

Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round.